PTLF (Petlife Pharmaceuticals) Total Operating Expense: $2.39 Mil (TTM As of Feb. 2018)


What is Petlife Pharmaceuticals Total Operating Expense?

Petlife Pharmaceuticals PTLF Total Operating Expense is $2.39 Mil as of Feb. 2018.

Petlife Pharmaceuticals's Total Operating Expense for the three months ended in Feb. 2018 was $0.18 Mil. Petlife Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2018 was $2.39 Mil.

Petlife Pharmaceuticals Total Operating Expense Related Terms

Petlife Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Total Operating Expense Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 1.45 1.71 3.69 22.39

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.26 0.57 1.45 0.19 0.18

Petlife Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $2.39 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Total Operating Expense of $2.39 Mil as of Feb. 2018. Total operating expense is the primary recurring expense associated with central operations. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Total Operating Expense too high?
Petlife Pharmaceuticals' current Total Operating Expense is $2.39 Mil.
How does Petlife Pharmaceuticals' Total Operating Expense compare to PCYN and YBAO?
Petlife Pharmaceuticals' Total Operating Expense of $2.39 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Total Operating Expense is $2.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Total Operating Expense of $2.39 Mil. The current Total Operating Expense is $2.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Total Operating Expense is $2.39 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.